Episurf Medical will exhibit at the Unicompartmental Knee Meeting, held in Bristol, United Kingdom, on November 6

Episurf Medical (NASDAQ: EPIS B) will exhibit at the Unicompartmental Knee Meeting, held in Bristol (Ashton Gate Stadium), United Kingdom, on November 6. At this meeting, Dr Pieter Emans (University Hospital Maastricht, Netherlands) will further give a presentation on the advantages of the Episealer® implant and the latest clinical data from the ongoing European multicenter study.

For the full program, see www.unikneemeeting.org. For an overview of the industry conferences attended by Episurf Medical, see the following link: www.episurf.com/healthcare-professionals/conferences.

For more  information, please contact:
 

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalised treatment alternatives. Episurf Medical’s Episealer® personalised implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags:

About Us

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.